Starting with
transplants of human
oligodendrocytes in the late 1980s [40], and more recently with populations of human
oligodendrocyte progenitor cells isolated from the developing or adult CNS, or from human embryonic stem
cells, it has been possible to generate extensive myelination upon transplantation into spinal cord injury or into congenital mouse models of hypomyelination [41]--[48].